Betty Walker Richardson
Family Medicine · Tifton, GANPI 1679572648
Payments from drug & device makers
Across 68 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$139
- Merck$132
- Astellas Pharma US Inc$112
- AbbVie$105
- Sunovion Pharmaceuticals Inc.$87
- Lilly USA, LLC$82
- plus $426 from 16 others
What the payments were for
- Food & beverage$1,083100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,083 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 118 | $124,582 |
| TrulicityDulaglutide | 25 | $28,435 |
| FarxigaDapagliflozin Propanediol | 17 | $18,448 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $12,955 |
| EliquisApixaban | 18 | $10,856 |
| LinzessLinaclotide | 12 | $7,522 |
| BrilintaTicagrelor | 25 | $6,472 |
| LivaloPitavastatin Calcium | 11 | $3,513 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $1,869 |
| FenofibrateFenofibrate Nanocrystallized | 80 | $1,652 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,263 |
| Atorvastatin Calcium | 205 | $1,225 |
| Gabapentin | 96 | $1,192 |
| LantusInsulin Glargine,hum.Rec.Anlog | 11 | $1,037 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,007 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $13 | $124,582118 claims |
| Lilly USA, LLCTrulicity | $82 | $28,43525 claims |
| AstraZenecaFarxiga, Brilinta | $70 | $24,91942 claims |
| PfizerEliquis | $33 | $10,85618 claims |
| AbbVieLinzess | $105 | $7,52212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Tifton
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.